Paxlovid Vindicated for Younger COVID Patients CDC study supports similar benefit in those under 50 as in seniors Nov 22, 2022
Anticoagulation Again Flops for Outpatient COVID-19 Largest-yet RCT shows no benefit for non-hospitalized symptomatic patients despite elevated risk Nov 08, 2022
Moving Fast on HF Drugs After Acute Hospitalization Holds Big Outcome Benefit Randomized trial shows advantages across heart failure spectrum Nov 07, 2022
Bivalirudin Crowned as Better Anticoagulant for Primary PCI in STEMI BRIGHT-4 trial hands the drug a "clear, unambiguous win" against heparin Nov 07, 2022
Early Invasive Strategy for Stable CAD Holds No Long-Term Survival Advantage Extended follow-up of ISCHEMIA trial weighs in on mortality Nov 07, 2022
Definitive Answer on Steroids for Infant Heart Surgery Falls Short STRESS trial misses primary endpoint but secondary benefits are suggestive Nov 06, 2022
Diuretics on Par in Head-to-Head Comparison for Hypertension But a surprise signal emerges for one group in pragmatic trial Nov 06, 2022
CPR Less Likely for Black, Hispanic People Association seen even for witnessed cardiac arrest in the home and in diverse neighborhoods Oct 27, 2022
Extra Mobilization Doesn't Save Lives, Time in the ICU Randomized trial may suggest that the "dose" from good usual care is enough Oct 26, 2022
What to Know About Medical Therapy for Cardiomyopathy Along with the "four pillars" for heart failure, specific considerations shape care across cardiomyopathies Oct 18, 2022